Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-136862
Filing Date
2017-04-25
Accepted
2017-04-25 16:45:58
Documents
11
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d364332d10ka.htm 10-K/A 810701
2 EX-31.3 d364332dex313.htm EX-31.3 3194
3 EX-31.4 d364332dex314.htm EX-31.4 3216
4 GRAPHIC g364332g03d30.jpg GRAPHIC 43541
5 GRAPHIC g364332g08j26.jpg GRAPHIC 228098
6 GRAPHIC g364332g23v81.jpg GRAPHIC 97308
7 GRAPHIC g364332g46h67.jpg GRAPHIC 131041
8 GRAPHIC g364332g47r37.jpg GRAPHIC 45423
9 GRAPHIC g364332g81n44.jpg GRAPHIC 102057
10 GRAPHIC g364332g96z10.jpg GRAPHIC 44930
11 GRAPHIC g364332g99d34.jpg GRAPHIC 175106
  Complete submission text file 0001193125-17-136862.txt   2014389
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33500 | Film No.: 17781613
SIC: 2834 Pharmaceutical Preparations